Vaccinated, low-risk people won’t benefit from COVID-19 pill Paxlovid: Pfizer study suggests
(WASHINGTON) -- Pfizer's COVID-19 treatment Paxlovid has been hailed as a breakthrough in the fight against COVID-19. The pills have shown to dramatically reduce the risk of being hospitalized or dying for people who are at high-risk of COVID-19.But mounting evidence suggests Paxlovid may... Read More.
